Tiziana Life Sciences Ltd
- Last sale
- Nov 12, 2026 · -0.44%
- Market cap
- $74.44M
- 120.51M shares
- Filings
- 496
—
—
—FY 2024N/M FY24 yoy
FY 2024N/M FY24 yoy
FY 2024derivedN/M FY24 yoy
FY 2024N/M FY24 yoy
FY 2024+214.8% FY24 yoy
- $74.44M
- —
- —
- —
- —
- —
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $5,229,000 | reported | |
| FY 2023 | 2023-12-31 | $8,113,000 | reported | |
| FY 2022 | 2022-12-31 | $12,955,000 | reported | |
| FY 2021 | 2021-12-31 | $13,208,000 | reported | |
| FY 2020 | 2020-12-31 | $5,993,000 | reported | |
| FY 2019 | 2019-12-31 | $3,714,000 | reported | |
| FY 2018 | 2018-12-31 | $5,510,000 | reported | |
| FY 2017 | 2017-12-31 | $6,015,000 | reported | |
| FY 2016 | 2016-12-31 | $4,007,000 | reported |
Pharmaceutical preparations
Tiziana Life Sciences Ltd is the 307th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
MISTMilestone Pharmaceuticals Inc.———$81.0MZOMDFZomedica Corp.$32.0M17.4%255.6%$78.4MCOYACoya Therapeutics, Inc.$7.9M123.6%267.1%$75.8MRANIRani Therapeutics Holdings, Inc.$1.6M58.9%1,817.1%$75.6M
TLSATiziana Life Sciences Ltd (this company)———$74.4M
TENXTenax Therapeutics, Inc.$0.0——$72.9MMNOVMedicinova Inc$409.7K—2,928.8%$72.0MZYBTZhengye Biotechnology Holding Ltd$16.6M34.8%60.0%$71.6MCRBPCorbus Pharmaceuticals Holdings, Inc.———$70.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Tiziana Life Sciences Ltd · CIK 1723069 · Engraved from SEC EDGAR